Veradermics MANE
NYSE MANE
$151.51 +3.07 (+2.07%)
As of: Nov 11, 2026 · 11:32 AM EST

Veradermics (MANE) Change in Account Payables (2025 - 2026)

Updated

Veradermics (MANE) posted Change in Account Payables of $4.85 million for Q2 2026, compared with -$1.03 million a year earlier.

Analysis

Veradermics (MANE) Change in Account Payables (2025 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Change in Account Payables at Veradermics was $2.08 million; for FY2025, it was -$122,000.

  • In prior years, Veradermics' Change in Account Payables was $646,000 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Payables (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 83.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 254.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Veradermics 822.06 Mn -1.33 Bn - -4.01 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -4.01 Mn
Jun 30, 2026 4.85 Mn
Mar 31, 2026 -1.06 Mn
Dec 31, 2025 141,000.00
Sep 30, 2025 1.45 Mn
Jun 30, 2025 -1.03 Mn
Mar 31, 2025 -686,000.00
API Access

Veradermics Change in Account Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-account-payables&ticker=MANE&period=max&api_key=YOUR_API_KEY